NO137341C
(en)
*
|
1972-10-02 |
1978-02-15 |
Tavolek Laboratories |
RODENTICID PREPARATION INCLUDING COATED PARTICLES OF SUBSTITUTED NORBORNEN DIKAR BOXIMIDES
|
DE2532147B2
(en)
*
|
1975-07-18 |
1981-06-25 |
Renker GmbH, 5160 Düren |
Process for the production of microcapsules containing oil
|
US4357259A
(en)
*
|
1977-08-01 |
1982-11-02 |
Northwestern University |
Method of incorporating water-soluble heat-sensitive therapeutic agents in albumin microspheres
|
US4247406A
(en)
|
1979-04-23 |
1981-01-27 |
Widder Kenneth J |
Intravascularly-administrable, magnetically-localizable biodegradable carrier
|
WO1985005029A1
(en)
*
|
1984-05-09 |
1985-11-21 |
Medaphore Inc. |
Oral insulin and a method of making the same
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
US6099856A
(en)
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US6331318B1
(en)
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
US5578323A
(en)
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5447728A
(en)
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5629020A
(en)
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5714167A
(en)
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5541155A
(en)
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US5443841A
(en)
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5792451A
(en)
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5811127A
(en)
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US5401516A
(en)
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5709861A
(en)
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5958457A
(en)
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
JP4361601B2
(en)
|
1993-04-22 |
2009-11-11 |
エミスフェアー・テクノロジーズ・インク |
Oral drug transfer composition and method
|
FR2727632A1
(en)
*
|
1994-12-06 |
1996-06-07 |
Godard Philippe |
Compsns. contg. perfume-filled microcapsules
|
US5965121A
(en)
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6090958A
(en)
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
CN1151836C
(en)
|
1995-03-31 |
2004-06-02 |
艾米斯菲尔技术有限公司 |
Compound and compositions for delivering active agents
|
US5650386A
(en)
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
US5989539A
(en)
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US5824345A
(en)
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
US6051258A
(en)
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US6084112A
(en)
|
1995-09-11 |
2000-07-04 |
Emisphere Technologies, Inc. |
Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
|
JP2000512671A
(en)
|
1996-06-14 |
2000-09-26 |
エミスフェアー テクノロジーズ インク |
Microencapsulated fragrance and preparation method
|
US5990166A
(en)
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5939381A
(en)
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5863944A
(en)
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US9822364B2
(en)
|
2008-03-11 |
2017-11-21 |
Yale University |
Compositions and methods for controlled delivery of inhibitory ribonucleic acids
|
EP2306991B1
(en)
|
2008-06-27 |
2019-12-25 |
Tepha, Inc. |
Injectable delivery of microparticles and compositions therefore
|
US9339529B2
(en)
|
2012-02-17 |
2016-05-17 |
Massachusetts Institute Of Technology |
Glucose-responsive microgels for closed loop insulin delivery
|
CA2867381C
(en)
|
2012-03-16 |
2016-09-20 |
The Johns Hopkins University |
Controlled release formulations for the delivery of hif-1 inhibitors
|
CN104394891B
(en)
|
2012-03-16 |
2019-04-16 |
约翰霍普金斯大学 |
For delivering non-linear segmented copolymer-drug conjugates of activating agent
|
WO2014160404A1
(en)
|
2013-03-13 |
2014-10-02 |
The Regents Of The University Of California |
Improved oral drug devices and drug formulations
|
RU2016133040A
(en)
|
2014-01-10 |
2018-02-14 |
ЧАМБЕР ВОРКС, ЭлЭлСи |
PERSONALIZING SUBSTANCE FOR APPLICATION TO SKIN OR ADDITION TO TATTOO INK AND METHODS FOR PRODUCING IT
|
WO2015138951A1
(en)
|
2014-03-14 |
2015-09-17 |
Chamber Works, Llc |
Articles of jewelry containing a personalizing additive such as dna and methods of making
|
EP3721875B1
(en)
|
2014-05-09 |
2023-11-08 |
Yale University |
Particles coated with hyperbranched polyglycerol and methods for their preparation
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
EP3179985A1
(en)
|
2014-08-14 |
2017-06-21 |
Brown University |
Compositions for stabilizing and delivering proteins
|
CN107278151A
(en)
|
2014-12-15 |
2017-10-20 |
约翰霍普金斯大学 |
Sutent preparation and its application method in treatment glaucoma
|
JP2018503736A
(en)
|
2015-01-20 |
2018-02-08 |
ザ ジョーンズ ホプキンズ ユニバーシティThe Johns Hopkins University |
Composition for sustained release of anti-glaucoma agent that suppresses intraocular pressure
|
WO2017035408A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Compounds for treatment of immune and inflammatory disorders
|
AR106018A1
(en)
|
2015-08-26 |
2017-12-06 |
Achillion Pharmaceuticals Inc |
ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
CA2997442C
(en)
|
2015-09-04 |
2021-01-26 |
Yale University |
Polymeric bile acid nanocompositions targeting the pancreas and colon
|
WO2017083779A1
(en)
|
2015-11-12 |
2017-05-18 |
Graybug Vision, Inc. |
Aggregating microparticles for therapy
|
EP3416976A2
(en)
|
2016-02-16 |
2018-12-26 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
CA3014795A1
(en)
|
2016-02-16 |
2017-08-24 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
WO2017151879A1
(en)
|
2016-03-02 |
2017-09-08 |
The Johns Hopkins University |
Compositions for sustained release of anti-glaucoma agents to control intraocular pressure
|
RU2018145364A
(en)
|
2016-06-27 |
2020-07-28 |
Ачиллион Фармасьютикалс, Инк. |
QUINAZOLINE AND INDOLE COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS
|
JP7262774B2
(en)
|
2016-09-13 |
2023-04-24 |
ノース カロライナ ステート ユニバーシティ |
Platelet compositions and methods for therapeutic agent delivery
|
WO2018187493A1
(en)
|
2017-04-04 |
2018-10-11 |
Yale University |
Compositions and methods for in utero delivery
|
CN111201040A
(en)
|
2017-05-10 |
2020-05-26 |
灰色视觉公司 |
Sustained release microparticles and suspensions thereof for medical therapy
|
US20210162013A1
(en)
|
2018-08-03 |
2021-06-03 |
Brown University |
Compositions and methods for improving the bioavailability of glp1 and analogues thereof
|
US20210189431A1
(en)
|
2018-08-10 |
2021-06-24 |
Yale University |
Compositions and methods for embryonic gene editing in vitro
|
CN116600789A
(en)
|
2020-06-19 |
2023-08-15 |
耶鲁大学 |
Polymeric bile acid ester nanoparticles for inducing tolerance
|
AU2021387970A1
(en)
|
2020-11-27 |
2023-06-29 |
General Nanotherapeutics Llc |
Methods and composition for treatment of immune-mediated diseases
|
US20230233691A1
(en)
|
2021-10-22 |
2023-07-27 |
University Of Houston System |
Methods and compositions for treating chronic inflammatory injury, metaplasia, dysplasia and cancers of epithelial tissues
|